Meningococcal polysaccharide (serogroups A,C,Y and W-135) diphtheria toxoid conjugate vaccine

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Meningococcal Immunization

Drug Information

Target Indication

Meningococcal Immunization

Clinical Trial

Last updated: 2/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SNY

Sanofi

Related Pipeline

Influenza (Healthy Volunteers)

Type 2 Diabetes Mellitus

Diphtheria

Non Small Cell Lung Cancer

Influenza